A highly sensitive micelle‐enhanced synchronous spectrofluorimetric determination of the recently approved co‐formulated drugs, bilastine and montelukast in pharmaceuticals and human plasma at nanogram levels.

MLA

Magdy, Galal, et al. “A Highly Sensitive Micelle‐enhanced Synchronous Spectrofluorimetric Determination of the Recently Approved Co‐formulated Drugs, Bilastine and Montelukast in Pharmaceuticals and Human Plasma at Nanogram Levels.” Luminescence: Journal of Biological & Chemical Luminescence, vol. 39, no. 2, Feb. 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1002/bio.4635.

APA

Magdy, G., El Hamd, M. A., El, M. M., Zainy, F. M., Mahdi, W. A., Alshehri, S., Alsaggaf, W. T., & Radwan, A. S. (2024). A highly sensitive micelle‐enhanced synchronous spectrofluorimetric determination of the recently approved co‐formulated drugs, bilastine and montelukast in pharmaceuticals and human plasma at nanogram levels. Luminescence: Journal of Biological & Chemical Luminescence, 39(2), 1–11. https://doi.org/10.1002/bio.4635

Chicago

Magdy, Galal, Mohamed A. El Hamd, Maghrabey, Mahmoud El, Faten M. Zainy, Wael A. Mahdi, Sultan Alshehri, Wejdan T. Alsaggaf, and Aya Saad Radwan. 2024. “A Highly Sensitive Micelle‐enhanced Synchronous Spectrofluorimetric Determination of the Recently Approved Co‐formulated Drugs, Bilastine and Montelukast in Pharmaceuticals and Human Plasma at Nanogram Levels.” Luminescence: Journal of Biological & Chemical Luminescence 39 (2): 1–11. doi:10.1002/bio.4635.